Customization: | Available |
---|---|
Name: | Oleanolic Acid Tablets |
Transport Package: | Carton |
Still deciding? Get samples of US$ 50/Piece
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
[Drug name]
General name: oleanolic acid tablets
Product name: oleanolic acid tablet (Yunpeng)
Oleanolicacidtablets
Pinyin full code: Qidunguosuanpian
Main Ingredients Each piece of this product contains 10 mg of olenolic acid, and the auxiliary materials are fillers: starch and sucrose. Lubricants: talcum powder, magnesium stearate; Surfactant: sodium dodecyl sulfate; Disintegrating agent: sodium carboxymethyl starch.
"Into a"
3β-hydroxy- Olea-12-en-28-OIC acid
Molecular Weight: C30H48O3
The product is a kind of white piece.
[Indications/Function] For adjuvant treatment of acute and chronic hepatitis.
Specification model 20mg*100s
[Usage and Dosage] Oral, adult, acute hepatitis 2 ~ 4 tablets once, chronic hepatitis 4 ~ 8 tablets once. Three times a day.
1. A few patients have dry mouth, diarrhea and discomfort in the upper abdomen, which can disappear after symptomatic treatment. 2. Slight reduction of platelets occurred in individual patients, which could be recovered after drug withdrawal.
[forbidden] is not clear.
1. This product is an adjuvant for the treatment of liver disease. Consult a physician before using this product for the first time. Regular visits to the hospital should be made during treatment. 2. Consult your physician or pharmacist for dosage for children. 3. In case of overdose or serious adverse reactions, seek medical advice immediately. 4. People who are allergic to this product should not use it. People who are allergic should use it with caution. 5. It is forbidden to use this product when its properties change. 6. Keep the product out of reach of children. 7. Children must be supervised by an adult. Please read the instructions carefully and follow the doctor's advice.
[Children's medication] no relevant research results.
[Elderly patients with medication] no relevant research results.
[Medication for pregnant and lactating women] There are no relevant research results.
[Drug interactions] Drug interactions may occur if taken with other drugs. Please consult your physician or pharmacist for details.
[Drug overdose] is not clear.
[Pharmacological Toxicology] This product has a certain protective effect on liver injury, can make the elevated serum alanine aminotransferase decrease, promote the regeneration of liver cells, accelerate the repair of necrotic tissue.
[Pharmacokinetics] is not clear.
To preserve in sealed storage.
[Packed] 100 tablets/bottle
[Effective period] 24 months
[Executive Standard] Ministry of Health Drug Standards (Part II) Volume III
[Approval Number] National medicine approval H14023932